Ranks as the third most frequently mutated gene in lung adenocarcinoma and demonstrates a significant co-mutation propensity with KRAS mutations, collectively defining the distinct biological KL (KRAS/STK11 co-mutant subtype). The gene discussed is STK11; the disease is lung adenocarcinoma.